Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes and Liquid Biopsies Asia 2016

Jorge Goldstein's Biography



Jorge Goldstein, Senior Director, Sterne Kessler Goldstein and Fox PLLC

Jorge Goldstein is a founding director of Sterne Kessler Goldstein and Fox, PLLC, a 300+ person IP law firm in Washington DC. He founded its Biotech/Chem Practice in 1983 and, after serving as Managing Director and Practice Chair for many years, is now Chair of its Human Rights/IP pro bono practice. This is a unique effort that bridges IP law with international human rights law dealing with Economic Social and Cultural Rights. The pro bono practice is involved with indigenous IP rights, the Nagoya Protocol on Access and Benefit Sharing, access to essential medicines, and other related topics of importance in the ESC space. He is active in IP strategy, litigation and licensing. Dr. Goldstein has close to 40 years of experience in preparing, prosecuting, licensing, enforcing and litigating biotech patents. Noteworthy among several of his appellate U.S. cases, in 1988 Goldstein was lead counsel in In re Wands et al. 8 USPQ2d 1400 (Fed. Cir.), a pivotal decision on biotechnology enablement. Born in Buenos Aires, Argentina, he received a PhD in Chemistry from Harvard in 1976, and a JD from the George Washington University in 1982. He is an invited professor of law and teaches a yearly course on Patentes en Biotecnología at the Universidad Austral, Buenos Aires. The course is part of that institution's Master's Program in IP, sponsored by WIPO. The Legal Times of Washington, Chambers USA, and Legal 500 have repeatedly named him a Leading Lawyer and he was, in 2013, named "Lawyer of the Year in Biotechnology" by Best Lawyers in America.

Jorge Goldstein Image

Breakfast Briefing: The Patent Landscape of Precision Medicine in the USA: How Recent Court Decisions Will Affect this Rapidly Growing Field

Friday, 8 April 2016 at 08:00

Add to Calendar ▼2016-04-08 08:00:002016-04-08 09:00:00Europe/LondonBreakfast Briefing: The Patent Landscape of Precision Medicine in the USA: How Recent Court Decisions Will Affect this Rapidly Growing FieldExosomes and Liquid Biopsies Asia 2016 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com

There have been dramatic legal changes in the USA on the patent eligibility of natural correlations (where a patent claim is drawn to a genetic diagnostic method of determining propensity to disease) and on the concept of "split infringement" (where two different parties, such as a clinical lab and a physician, each carry out one of a two-step patented process, such as detecting a mutation and then administering a personalized drug). These legal changes  have led to severe  problems with the patent protection and enforcement of precision medicine methods. We will discuss these legal developments and propose solutions.


Add to Calendar ▼2016-04-07 00:00:002016-04-08 00:00:00Europe/LondonExosomes and Liquid Biopsies Asia 2016Exosomes and Liquid Biopsies Asia 2016 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com